Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Artivion Inc AORT

Artivion, Inc. is a medical device company engaged in the manufacturing, processing, and distribution of medical devices and implantable human tissues used in cardiac and vascular surgical procedures for patients with aortic disease, heart valve disease, aortic aneurysms, and dissections. The Company's segments include Medical Devices and Preservation Services. The Medical Devices segment includes sales of aortic stent grafts, surgical sealants, and On-X. The Preservation Services segment includes services for the preservation of cardiac and vascular implantable human tissues. It has four product families: aortic stent grafts, surgical sealants, On-X mechanical heart valves and related surgical products, and implantable cardiac and vascular human tissues. Aortic stent grafts include aortic arch stent grafts, abdominal stent grafts, and synthetic vascular grafts. Surgical sealants include BioGlue Surgical Adhesive products. It also sells or distributes PhotoFix bovine surgical patches.


NYSE:AORT - Post by User

Bullboard Posts
Post by SurajKGuptaon Feb 29, 2008 5:21pm
260 Views
Post# 14576676

Cryolife Inc., A Sleeper Stock?

Cryolife Inc., A Sleeper Stock?Cryolife Inc. could be a sleeper stock that may persevere through the recession.  Just a week ago, Cryolife announced an annual profit of over $7 million.  Their 4th quarter showed a net income of 10 cents per share, as opposed to the loss they incurred in the 4th quarter of 2006.  Cryolife fell today at about the same rate that the market fell (just under 3%) due to the bad earnings reports and economic reports posted.  However, they seem to be performing well and they have a good potential to show high returns.  My recommendation for this stock would be to wait a few weeks after the effects of these initial bad earnings reports for other companies wears off.  I would recommend buying this stock before their 1st quarter results are announced, because I have an inkling that it will be better than they expect.  Personally, in markets like this I prefer short term investing, so I would sell CRY after you have posted some short-term gains.
Bullboard Posts